Recursion Pharmaceuticals-a logo

Recursion Pharmaceuticals-a share price today

(RXRX)

Recursion Pharmaceuticals-a share price is $7.95 & ₹682.19 as on 7 Jan 2025, 2.30 'hrs' IST

$7.95

0.15

(1.92%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Recursion Pharmaceuticals-a share price in Dollar and Rupees. Guide to invest in Recursion Pharmaceuticals-a stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Recursion Pharmaceuticals-a, along with analyst recommendations, forecasts, and comprehensive financials.

Recursion Pharmaceuticals-a share price movements

  • Today's Low: $7.90
    Today's High: $8.62

    Day's Volatility :8.33%

  • 52 Weeks Low: $5.60
    52 Weeks High: $15.74

    52 Weeks Volatility :64.42%

Recursion Pharmaceuticals-a Returns

PeriodRecursion Pharmaceuticals-aSector (Health Care)Index (Russel 2000)
3 Months
21.12%
-8.4%
0.0%
6 Months
4.84%
-3.8%
0.0%
1 Year
-38.14%
-0.1%
0.0%
3 Years
-49.48%
2.9%
-19.8%

Recursion Pharmaceuticals-a Key Statistics

in dollars & INR

Previous Close
$7.8
Open
$8.03
Today's High
$8.6183
Today's Low
$7.9
Market Capitalization
$2.6B
Today's Volume
$15.6M
52 Week High
$15.74
52 Week Low
$5.6
Revenue TTM
$65.2M
EBITDA
$-364.2M
Earnings Per Share (EPS)
$-1.54
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-78.49%

How to invest in Recursion Pharmaceuticals-a from India?

It is very easy for Indian residents to invest directly in Recursion Pharmaceuticals-a from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Recursion Pharmaceuticals-a stock in both Indian Rupees (INR) and US Dollars (USD). Search for Recursion Pharmaceuticals-a or RXRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Recursion Pharmaceuticals-a or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Recursion Pharmaceuticals-a shares which would translate to 0.108 fractional shares of Recursion Pharmaceuticals-a as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Recursion Pharmaceuticals-a, in just a few clicks!

Returns in Recursion Pharmaceuticals-a for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Recursion Pharmaceuticals-a investment value today

Current value as on today

₹66,268

Returns

₹33,732

(-33.73%)

Returns from Recursion Pharmaceuticals-a Stock

₹36,955 (-36.95%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Recursion Pharmaceuticals-a

15.09%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Investment in Recursion Pharmaceuticals-a from India has grown in the last 30 days as on Jan 7, 2025. 15.09% more purchase transactions for Recursion Pharmaceuticals-a in the last 30 days versus the previous period.

-3%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Recursion Pharmaceuticals-a on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -3% less investors are searching Recursion Pharmaceuticals-a in the last 30 days versus the previous period.

Global Institutional Holdings in Recursion Pharmaceuticals-a

  • ARK Investment Management LLC

    8.39%

  • Baillie Gifford & Co Limited.

    6.46%

  • Vanguard Group Inc

    6.21%

  • BlackRock Inc

    4.43%

  • RA Capital Management, LLC

    3.94%

  • Mubadala Investment Company PJSC

    3.32%

Analyst Recommendation on Recursion Pharmaceuticals-a

Buy

    53%Buy

    46%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Recursion Pharmaceuticals-a(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
6
6
6
Sell
0
0
0

Analyst Forecast on Recursion Pharmaceuticals-a

What analysts predicted

Upside of 23.99%

Current:

$7.95

Target:

$9.86

Insights on Recursion Pharmaceuticals-a

  • Price Movement

    In the last 7 days, RXRX stock has moved up by 15.2%
  • Increasing Revenue

    Revenue is up for the last 5 quarters, 10.10M → 26.08M (in $), with an average increase of 19.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -97.54M → -95.67M (in $), with an average increase of 2.0% per quarter
  • RXRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 58.3%
  • RXRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 107.9%
  • Price to Sales

    ForRXRX every $1 of sales, investors are willing to pay $29.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Recursion Pharmaceuticals-a Financials in INR & Dollars

FY19Y/Y Change
Revenue
$1.7M
-
Net Income
$-62.5M
-
Net Profit Margin
-3.7K%
-
FY20Y/Y Change
Revenue
$3.4M
↑ 99.47%
Net Income
$-87.9M
↑ 40.55%
Net Profit Margin
-2.6K%
↑ 1079.38%
FY21Y/Y Change
Revenue
$10.0M
↑ 193.0%
Net Income
$-178.1M
↑ 102.63%
Net Profit Margin
-1.8K%
↑ 794.18%
FY22Y/Y Change
Revenue
$39.7M
↑ 296.81%
Net Income
$-239.4M
↑ 34.45%
Net Profit Margin
-603.36%
↑ 1177.38%
FY23Y/Y Change
Revenue
$44.6M
↑ 12.33%
Net Income
$-328.1M
↑ 37.02%
Net Profit Margin
-735.99%
↓ 132.63%
Q2 FY23Q/Q Change
Revenue
$11.0M
↓ 9.21%
Net Income
$-76.7M
↑ 26.22%
Net Profit Margin
-696.5%
↓ 195.52%
Q3 FY23Q/Q Change
Revenue
$10.1M
↓ 8.3%
Net Income
$-93.0M
↑ 21.23%
Net Profit Margin
-920.78%
↓ 224.28%
Q4 FY23Q/Q Change
Revenue
$10.9M
↑ 7.81%
Net Income
$-93.0M
↓ 0.02%
Net Profit Margin
-853.88%
↑ 66.9%
Q1 FY24Q/Q Change
Revenue
$13.8M
↑ 26.66%
Net Income
$-91.4M
↓ 1.75%
Net Profit Margin
-662.41%
↑ 191.47%
Q2 FY24Q/Q Change
Revenue
$14.4M
↑ 4.52%
Net Income
$-97.5M
↑ 6.75%
Net Profit Margin
-676.56%
↓ 14.15%
Q3 FY24Q/Q Change
Revenue
$26.1M
↑ 80.91%
Net Income
$-95.7M
↓ 1.91%
Net Profit Margin
-366.82%
↑ 309.74%
FY19Y/Y Change
Profit
$-44.1M
-
FY20Y/Y Change
Profit
$-59.9M
↑ 35.85%
FY21Y/Y Change
Profit
$10.0M
↓ 116.69%
FY22Y/Y Change
Profit
$-8.6M
↓ 185.94%
FY23Y/Y Change
Profit
$2.0M
↓ 123.13%
Q2 FY23Q/Q Change
Profit
$1.6M
↓ 620.38%
Q3 FY23Q/Q Change
Profit
$-775.0K
↓ 147.43%
Q4 FY23Q/Q Change
Profit
$-12.6M
↑ 1524.52%
Q1 FY24Q/Q Change
Profit
$-772.0K
↓ 93.87%
Q2 FY24Q/Q Change
Profit
$1.3M
↓ 270.73%
Q3 FY24Q/Q Change
Profit
$14.0M
↑ 962.44%
FY19Y/Y Change
Operating Cash Flow
$-57.0M
-
Investing Cash Flow
$-3.9M
-
Financing Cash Flow
$120.4M
-
FY20Y/Y Change
Operating Cash Flow
$-45.4M
↓ 20.41%
Investing Cash Flow
$-8.7M
↑ 123.53%
Financing Cash Flow
$246.1M
↑ 104.41%
FY21Y/Y Change
Operating Cash Flow
$-158.6M
↑ 249.38%
Investing Cash Flow
$-271.7M
↑ 3009.2%
Financing Cash Flow
$458.5M
↑ 86.3%
FY22Y/Y Change
Operating Cash Flow
$-83.5M
↓ 47.34%
Investing Cash Flow
$193.2M
↓ 171.11%
Financing Cash Flow
$154.3M
↓ 66.34%
Q2 FY23Q/Q Change
Operating Cash Flow
$-67.5M
↓ 7.98%
Investing Cash Flow
$-2.1M
↓ 61.55%
Financing Cash Flow
$3.8M
↑ 97.03%

Recursion Pharmaceuticals-a Technicals Summary

Sell

Neutral

Buy

Recursion Pharmaceuticals-a is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Recursion Pharmaceuticals-a Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Recursion Pharmaceuticals-a
-5.68%
4.84%
-38.14%
-49.48%
-72.61%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Recursion Pharmaceuticals-a
NA
NA
NA
-1.54
-0.78
-0.36
NA
1.83
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Recursion Pharmaceuticals-a
Buy
$2.6B
-72.61%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

Recursion Pharmaceuticals-a Dividend announcements

  • Recursion Pharmaceuticals-a Earnings

    Recursion Pharmaceuticals-a’s price-to-earnings ratio stands at None

    Read More

About Recursion Pharmaceuticals-a

recursion pharmaceuticals has developed a powerful drug discovery platform involving millions of rapid, automated experiments and analysis to discover new therapeutics. our platform has resulted in the massive parallelization of drug discovery. we have deployed this platform in pursuit of drugs for the treatment of rare genetic diseases. we partner or out-license these leads to major pharmaceutical companies early in development. our horizontal business model focused on discovery accelerates our impact and reduces our costs by avoiding slow and costly in-house development, and allows us to spread risk across many new therapeutic opportunities.
Organization
Recursion Pharmaceuticals-a
Employees
500
CEO
Dr. Christopher C. Gibson Ph.D.
Industry
Services

Management People of Recursion Pharmaceuticals-a

NameTitle
Dr. Christopher C. Gibson Ph.D.
Co-Founder, CEO & Director
Dr. Blake C. Borgeson Ph.D.
Co-Founder & Director
Dr. David J. Mauro M.D., Ph.D.
Chief Medical Officer
Mr. Ben R. Taylor
CFO & President of Recursion UK
Ms. Kristen Rushton M.B.A.
Chief Operating Officer
Kevin Leggat
Vice President of Finance & Accounting
Mr. Benjamin Mabey M.S.
Chief Technology Officer
Dr. David Hallett Ph.D.
Chief Scientific Officer
Mr. Jared Allenbach
Senior Director of Investor Relations
Mr. Nathan Hatfield
Chief Legal Officer & General Counsel

Important FAQs about investing in Recursion Pharmaceuticals-a from India :

What is Recursion Pharmaceuticals-a share price today?

Recursion Pharmaceuticals-a share price today stands at $7.95, Open: $8.03 ; Previous Close: $7.80 ; High: $8.62 ; Low: $7.90 ; 52 Week High: $15.74 ; 52 Week Low: $5.60. The stock opens at $8.03, after a previous close of $7.80. The stock reached a daily high of $8.62 and a low of $7.90, with a 52-week high of $15.74 and a 52-week low of $5.60.

Can Indians buy Recursion Pharmaceuticals-a shares?

Yes, Indians can invest in the Recursion Pharmaceuticals-a (RXRX) from India.

With INDmoney, you can buy Recursion Pharmaceuticals-a at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Recursion Pharmaceuticals-a at zero transaction cost.

How can I buy Recursion Pharmaceuticals-a shares from India?

It is very easy to buy Recursion Pharmaceuticals-a from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Recursion Pharmaceuticals-a be purchased?

Yes, you can buy fractional shares of Recursion Pharmaceuticals-a with INDmoney app.

What are the documents required to start investing in Recursion Pharmaceuticals-a stocks?

To start investing in Recursion Pharmaceuticals-a, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Recursion Pharmaceuticals-a

Today’s highest price of Recursion Pharmaceuticals-a (RXRX) is $8.62.

Today’s lowest price of Recursion Pharmaceuticals-a (RXRX) is $7.90.

What is today's market capitalisation of Recursion Pharmaceuticals-a

Today's market capitalisation of Recursion Pharmaceuticals-a RXRX is 2.6B

What is the 52 Week High and Low Range of Recursion Pharmaceuticals-a

  • 52 Week High

    $15.74

  • 52 Week Low

    $5.60

What are the historical returns of Recursion Pharmaceuticals-a?

  • 1 Month Returns

    -5.68%

  • 3 Months Returns

    4.84%

  • 1 Year Returns

    -38.14%

  • 5 Years Returns

    -72.61%

Who is the Chief Executive Officer (CEO) of Recursion Pharmaceuticals-a

Dr. Christopher C. Gibson Ph.D. is the current Chief Executive Officer (CEO) of Recursion Pharmaceuticals-a.